Note: To capture the full content of this document, please select landscape mode (11" x 8.5") when printing.

Schedule K
(Form 990)
Department of the Treasury
Internal Revenue Service
Supplemental Information on Tax-Exempt Bonds
SchKMediumBullet Complete if the organization answered "Yes" to Form 990, Part Ⅵ, line 24a. Provide descriptions,
explanations, and any additional information in Part Ⅵ.
SchKMediumBullet Attach to Form 990.
SchKMediumBulletGo to www.irs.gov/Form990 for instructions and the latest information.
OMB No. 1545-0047
2019
Open to Public
Inspection
Name of the organization
University of Maryland Medical System Corporation
 
Employer identification number
52-1362793
Part Ⅰ
Bond Issues
(a) Issuer name (b) Issuer EIN (c) CUSIP # (d) Date issued (e) Issue price (f) Description of purpose (g) Defeased (h) On
behalf of
issuer		 (i) Pool
financing
Yes No Yes No Yes No
A MHHEFA (SERIES 2007A&B)
  		52-0936091 574217G74 09-12-2007 137,795,000 ADVANCED REFUNDING OF SERIES 2002 BONDS, AND SERIES 2001 BONDS X     X   X
B MHHEFA (SERIES 2008A-E)
  		52-0936091 574217U78 05-21-2008 280,000,000 CURRENT REFUNDING- 2006B-F BONDS X     X   X
C MHHEFA (SERIES 2008F)
  		52-0936091 574217Y66 07-10-2008 89,764,001 CURRENT REFUNDING- 2006B-F BONDS   X   X   X
D MHHEFA (SERIES 2010)
  		52-0936091 5742175D3 01-07-2010 241,441,656 FINANCE 2010 FACILITY COSTS; AND REFUND SERIES 2008G, SERIES 2008H AND SERIES 2004A BONDS   X   X   X
Part Ⅱ
Proceeds
A B C D
1 Amount of bonds retired .................. 20,195,000   66,787,005 104,321,695
2 Amount of bonds legally defeased .............. 41,175,000 175,000,000    
3 Total proceeds of issue .................. 137,849,502 280,000,000 89,951,422 243,598,715
4 Gross proceeds in reserve funds .............       17,980,097
5 Capitalized interest from proceeds .............        
6 Proceeds in refunding escrows ...............        
7 Issuance costs from proceeds ............... 1,120,731 1,586,410 792,457 2,656,305
8 Credit enhancement from proceeds ............. 19,824 188,590    
9 Working capital expenditures from proceeds .............        
10 Capital expenditures from proceeds .............       130,000,000
11 Other spent proceeds ............. 136,708,947 278,225,000 89,158,965 92,962,313
12 Other unspent proceeds .............        
13 Year of substantial completion ............. 2012
Yes No Yes No Yes No Yes No
14 Were the bonds issued as part of a current refunding issue of tax-exempt
bonds (or, if issued prior to 2018, a current refunding issue)? ........ 		  X X   X   X  
15 Were the bonds issued as part of an advance refunding issue of taxable
bonds (or, if issued prior to 2018, an advance refunding issue)? ........ 		X     X   X   X
16 Has the final allocation of proceeds been made? .......... X   X   X     X
17 Does the organization maintain adequate books and records to support the final allocation of proceeds? .................. X   X   X   X  
Part Ⅲ
Private Business Use
A B C D
Yes No Yes No Yes No Yes No
1 Was the organization a partner in a partnership, or a member of an LLC, which owned property financed by tax-exempt bonds? .............   X   X   X   X
2 Are there any lease arrangements that may result in private business use of bond-financed property? ...............   X   X   X   X
For Paperwork Reduction Act Notice, see the Instructions for Form 990.
Cat. No. 50193E
Schedule K (Form 990) 2019
Page 2

Schedule K (Form 990) 2019
Page 2
Part Ⅲ
Private Business Use (Continued)
A B C D
Yes No Yes No Yes No Yes No
3a Are there any management or service contracts that may result in private business use of bond-financed property? .............   X   X   X   X
b If "Yes" to line 3a, does the organization routinely engage bond counsel or other outside counsel to review any management or service contracts relating to the financed property?                
c Are there any research agreements that may result in private business use of bond-financed property? .............   X   X   X   X
d If "Yes" to line 3c, does the organization routinely engage bond counsel or other outside counsel to review any research agreements relating to the financed property?                
4 Enter the percentage of financed property used in a private business use by entities other than a section 501(c)(3) organization or a state or local government ....SchKMediumBullet        
5 Enter the percentage of financed property used in a private business use as a result of unrelated trade or business activity carried on by your organization, another section 501(c)(3) organization, or a state or local government ......... SchKMediumBullet        
6 Total of lines 4 and 5 ............. 0 % 0 % 0 % 0 %
7 Does the bond issue meet the private security or payment test? ...   X   X   X   X
8a Has there been a sale or disposition of any of the bond-financed property to a nongovernmental person other than a 501(c)(3) organization since the bonds were issued?.............   X   X   X   X
b If "Yes" to line 8a, enter the percentage of bond-financed property sold or disposed of. ..        
c If "Yes" to line 8a, was any remedial action taken pursuant to Regulations sections 1.141-12 and 1.145-2? .............                
9 Has the organization established written procedures to ensure that all nonqualified bonds of the issue are remediated in accordance with the requirements under
Regulations sections 1.141-12 and 1.145-2? ........ 		X   X   X   X  
Part Ⅳ
Arbitrage
A B C D
Yes No Yes No Yes No Yes No
1 Has the issuer filed Form 8038-T, Arbitrage Rebate, Yield Reduction and Penalty in Lieu of Arbitrage Rebate? ...   X   X   X   X
2 If "No" to line 1, did the following apply? ....
a Rebate not due yet? .......   X   X   X   X
b Exception to rebate? ........   X   X   X   X
c No rebate due? ......... X   X   X   X  
If "Yes" to line 2c, provide in Part Ⅵ the date the rebate
computation was performed ......
3 Is the bond issue a variable rate issue? ..... X   X     X   X
4a Has the organization or the governmental issuer entered into a qualified hedge with respect to the bond issue? X   X     X   X
b Name of provider .......... JP MORGAN BANK OF AMERICA
  		JP MORGAN BANK OF AMERICA
  		 
  		 
 
c Term of hedge ......... 2700 % 3460 %    
d Was the hedge superintegrated? ......   X   X        
e Was the hedge terminated? ........   X   X        
Schedule K (Form 990) 2019
Page 3

Schedule K (Form 990) 2019
Page 3
Part Ⅳ
Arbitrage (Continued)
A B C D
Yes No Yes No Yes No Yes No
5a Were gross proceeds invested in a guaranteed investment contract (GIC)?   X   X   X   X
b Name of provider ..........  
  		 
  		 
  		 
 
c Term of GIC .........        
d Was the regulatory safe harbor for establishing the fair market value of the GIC satisfied? ........                
6 Were any gross proceeds invested beyond an available temporary period?   X   X   X   X
7 Has the organization established written procedures to monitor the requirements of section 148? ... X   X   X   X  
Part Ⅴ
Procedures To Undertake Corrective Action
--------------------------------------------------------------------------------------------------------------- A B C D
Yes No Yes No Yes No Yes No
Has the organization established written procedures to ensure that violations of federal tax requirements are timely identified and corrected through the voluntary closing agreement program if self-remediation is not available under applicable regulations? X   X   X   X  
Part Ⅵ
Supplemental Information. Provide additional information for responses to questions on Schedule K. (See instructions).
Return Reference Explanation
Schedule K, Part I, Column (f) Description of purpose ISSUER NAME: MHHEFA (SERIES 2013A) ACQUISITION COSTS RELATED TO ST. JOSEPH MEDICAL CENTER; FINANCE CAPITAL PROJECTS; AND REFUND SERIES 1998, SERIES 2004B AND SERIES 2005.
Schedule K, Part I, Column (f) Description of Purpose ISSUER NAME: MHHEFA (SERIES 2017D) BONDS TO FINANCE A PORTION OF ACQUISITION COSTS RELATED TO UM CAPITAL REGION AND CONSTRUCTION COSTS OF NEW REGIONAL MEDICAL CENTER AND NEW FREESTANDING MEDICAL FACILITY.
Schedule K, Part II, Line 3 MHHEFA (Series 2007A&B) The difference between the issue price and the total proceeds of issue is investment earnings in the amount of $54,502.
Schedule K, Part II, Line 3 MMHEFA (Series 2008F) The difference between the issue price and the total proceeds of issue is investment earnings in the amount of $187,421.
Schedule K, Part II, Line 3 MHHEFA (SERIES 2010) The difference between the issue price and the total proceeds of issue is investment earnings in the amount of $2,157,059.
Schedule K, Part II, Line 3 MHHEFA (SERIES 2013A) The difference between the issue price and the total proceeds of issue is investment earnings in the amount of $72,288.
Schedule K, Part II, Line 3 MHHEFA (SERIES 2015) The difference between the issue price and the total proceeds of issue is investment earnings in the amount of $3,496.
Schedule K, Part II, Line 3 MHHEFA (Series 2017B) The difference between the issue price and the total proceeds of issue is investment earnings in the amount of $5,958.
Schedule K, Part II, Line 3 MHHEFA (Series 2017D) The difference between the issue price and the total proceeds of issue is investment earnings in the amount of $2,989,131.
Schedule K, Part IV, Line 2c COLUMN A Issuer name: MHHEFA (SERIES 2007A&B) The calculation for computing no rebate due was performed on 07/01/2017
Schedule K, Part IV, Line 2c COLUMN B Issuer name: MHHEFA (SERIES 2008A-E) The calculation for computing no rebate due was performed on 07/01/2017
Schedule K, Part IV, Line 2c COLUMN C Issuer name: MHHEFA (SERIES 2008F) The calculation for computing no rebate due was performed on 07/01/2018
Schedule K, Part IV, Line 2c COLUMN D Issuer name: MHHEFA (SERIES 2010) The calculation for computing no rebate due was performed on 04/01/2019
Schedule K, Part IV, Line 2c COLUMN A Issuer name: MHHEFA (SERIES 2013A) The calculation for computing no rebate due was performed on 07/01/2017
Schedule K (Form 990) 2019

Additional Data


Software ID: 19010655
Software Version: 2019v5.0